cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome

SUMMARY: We report a case of metastatic pancreatic neuroendocrine carcinoma associated with paraneoplastic Cushing’s syndrome, successively treated with five lines of treatment (platin-etoposide, LV5FU2-dacarbazine, FOLFIRINOX, pembrolizumab, and paclitaxel) and anti-secretory treatment. Circulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerard, Laura, Barthelemy, David, Gauthier, Arnaud, Hervieu, Valerie, Lopez, Jonathan, Gibert, Benjamin, Lasolle, Helene, Chardon, Laurence, Garcia, Jessica, Raverot, Gérald, Payen, Léa, Walter, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265538/
https://www.ncbi.nlm.nih.gov/pubmed/37435182
http://dx.doi.org/10.1530/EO-21-0012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265538/
https://www.ncbi.nlm.nih.gov/pubmed/37435182
http://dx.doi.org/10.1530/EO-21-0012

Ejemplares similares